EBRO 2017

Background and Purpose

• Because tumors in BRCA mutation carriers might be more sensitive to radiation with increased risk of second primaries, we report after long term follow-up whether mutation status influenced the rate of ipsilateral tumors after breast-conserving treatment.

• A case-control study was performed